Q301--CYTOPATHOLOGY AND NEXT GENERATION SEQUENCING TESTING SERVICES

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

242-NETWORK CONTRACT OFFICE 02 (36C242)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C24226Q0875

NAICS

621511 - Medical Laboratories

Classification Code

Q301

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs, through its 242-Network Contract Office 02, has issued an award notice for the provision of Cytopathology and Next Generation Sequencing (NGS) Testing Services. This procurement, identified under solicitation number 36C24226Q0875, falls within the Medical Laboratories sector, as classified by NAICS code 621511 (2022 version), and is further categorized under Product Service Code Q301. The primary objective of this contract is to secure specialized laboratory testing services that encompass both cytopathology and advanced molecular diagnostics through next generation sequencing. These services are critical for supporting the diagnostic and treatment needs of the VA’s patient population, ensuring timely and accurate detection of cellular abnormalities and genetic markers that inform clinical decision-making. The scope of work likely includes the receipt, processing, and analysis of patient specimens, with the expectation of delivering precise and actionable laboratory results to VA healthcare providers. The intended outcomes of this procurement are to enhance the VA’s diagnostic capabilities, improve patient care through advanced laboratory testing, and ensure compliance with all relevant medical and regulatory standards. Contractors are expected to demonstrate expertise in cytopathology and NGS methodologies, maintain appropriate laboratory certifications, and adhere to stringent quality assurance protocols. The contracting activity is managed by the 242-Network Contract Office 02, a federal office within the Department of Veterans Affairs. Interested parties or stakeholders may direct inquiries to the primary point of contact, Mariangie Rivera, who can be reached via email at [email protected] or by phone at 518-626-6246. This award notice is currently active and was posted on January 10, 2026. Additional details, including any attachments related to the opportunity, can be accessed through the official SAM.gov listing at https://sam.gov/opp/0ddd709615cc4338910ba820bb705138/view. Contractors evaluating this opportunity should note that it is a federal procurement for specialized medical laboratory services, with a focus on advanced diagnostic testing. The requirements and deliverables are expected to remain consistent throughout the contract lifecycle, centering on the reliable provision of cytopathology and NGS testing in support of VA healthcare operations.